超声造影与CT及MRI对肝癌的诊断价值探讨

The value of contrast-enhanced ultrasound,CT and MRI in the diagnosis of liver cancer

目的:探讨超声造影、CT及MRI在肝癌临床诊断中的应用价值。方法:选取2014年1月-2019年7月就诊的83例疑似肝癌患者,均接受超声造影、CT及MRI检查。以病理诊断结果为金标准,分析超声造影、CT及MRI对肝癌的诊断价值。结果:83例患者经病理诊断确诊为良性病变19例(22.89%),恶性病变64例(77.11%);超声造影诊断肝癌的敏感性、准确性分别为96.88%,92.77%,高于CT(79.69%,75.90%)和MRI(87.50%,79.52%),差异有统计学意义(P<0.05);超声造影与CT,MRI诊断肝癌的特异性比较,差异无统计学意义(P>0.05)。结论:超声造影诊断肝癌的敏感性和准确性较高,可将其作为早期筛查肝癌的常用方法。

Objective:To explore the value of ultrasonography,CT and MRI in the clinical diagnosis of liver cancer.Methods:All 83 patients with suspected liver cancer who visited hospital from January 2014 to July 2019 were selected as the study subjects,all of them were examined by ultrasound,CT and MRI.The diagnostic efficacy of ultrasonography,CT and MRI in liver cancer was analyzed.Results:The sensitivity and accuracy of ultrasonography in the diagnosis of liver cancer were 96.88%,92.77%,higher than that of CT(79.69%,75.90%)and MRI(87.50%,79.52%),there was significient difference(P<0.05).There was no significant difference in the specificity of ultrasonography,CT and MRI in the diagnosis of liver cancer(P>0.05).Conclusion:Contrast-enhanced ultrasound has high sensitivity and accuracy in the diagnosis of liver cancer,and it can be used as a common method for early screening of liver cancer.